Transdermal absorption of memantine - Effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 1, 2012, Pages 164-170

  Del Rio Sancho, S ^a   Serna Jimenez C E ^a   Calatayud Pascual, M A ^a   Balaguer Fernandez C ^a   Femenia Font A ^a   Merino, V ^b   Lopez Castellano A ^a  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Alzheimer; Chemical enhancers; Iontophoresis; Memantine; Transdermal absorption

Indexed keywords

DECENOIC ACID; LAUROCAPRAM; LIMONENE; MEMANTINE; OCTANOL; OLEIC ACID; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; EXCIPIENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; ELECTRIC CURRENT; IN VITRO STUDY; IONTOPHORESIS; LIPOPHILICITY; NONHUMAN; PARTITION COEFFICIENT; SKIN ABSORPTION; TRANSDERMAL PATCH; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; INTRADERMAL DRUG ADMINISTRATION; PERMEABILITY; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; EXCITATORY AMINO ACID ANTAGONISTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IONTOPHORESIS; MEMANTINE; PERMEABILITY; SKIN ABSORPTION; SWINE;

EID: 84866009772     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.06.005     Document Type: Article

References (60)

1. K. McKeage Spotlight on memantine in moderate to severe Alzheimer's disease Drugs Aging 27 2010 177 179
2. R.J. van Marum Update on the use of memantine in Alzheimer's disease Neuropsychiatr. Dis. Treat. 5 2009 237 247
3. L. Osterberg, and T. Blaschke Adherence to medication New Engl. J. Med. 353 2005 487 497
4. C. McGraw, and V. Drennan Self-administration of medicine and older people Nurs. Stand. 15 2001 33 36
5. G. Small, and B. Dubois A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch Curr. Med. Res. Opin. 23 2007 2705 2713
6. J. Cummings, and B. Winblad A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia Expert Rev. Neurother. 7 2007 1457 1463
7. M. Emre, R. Bernabei, R. Blesa, R. Bullock, L. Cunha, H. Daniels, E. Dziadulewicz, H. Forstl, L. Frolich, T. Gabryelewicz, O. Levin, J. Lindesay, P. Martinez-Lage, A. Monsch, M. Tsolaki, and T. van Laar Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease CNS Neurosci. Ther. 16 2010 246 253
8. J.L. Cummings, M.R. Farlow, X. Meng, S. Tekin, and J.T. Olin Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease Clin. Drug Investig. 30 2010 41 49
9. N. Kanikkannan, K. Kandimalla, S.S. Lamba, and M. Singh Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery Curr. Med. Chem. 7 2000 593 608
10. R.R. Burnette Iontophoresis J. Hadgraft, R.H. Guy, Transdermal drug delivery 1989 Marcel Dekker, Inc. New York 274 291
11. R.R. Burnette, and B. Ongpipatanakul Characterization of the permselective properties of excised human skin during iontophoresis J. Pharm. Sci. 76 1987 765 773
12. R.H. Guy, N.K. Yogeshvar, M.B. Delgado-Charro, V. Merino, A. López, and D. Marro Iontophoresis: electrorepulsion and electroosmosis J. Control. Rel. 64 2000 129 132
13. R.H. Guy, M.B. Delgado-Charro, and Y.N. Kalia Iontophoretic transport across the skin Skin Pharmacol. Appl. Skin. Physiol. 14 Suppl 1 2001 35 40
14. Y.N. Kalia, A. Naik, J. Garrison, and R.H. Guy Iontophoretic drug delivery Adv. Drug Deliv. Rev. 56 2004 619 658
15. M.B. Delgado-Charro, and R.H. Guy Iontophoresis: applications in drug delivery and non-invasive monitoring J. Hadgraft, R.H. Guy, Transdermal Drug Delivery Systems 2003 Marcel Dekker, Inc. New York 199 225
16. P.G. Green, M. Flanagan, B. Shroot, and R.H. Guy Iontophoretic drug delivery K.A. Walters, J. Hadgraft, Pharmaceutical Skin Penetration Enhancement 1993 Marcel Dekker New York 311 333
17. T. Ghafourian, P. Zandasrar, H. Hamishekar, and A. Nokhodchi The effect of penetration enhancers on drug delivery through skin: a QSAR study J. Control. Release 99 2004 113 125
18. H.R. Moghimi, A.C. Williams, and B.W. Barry Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach J. Pharm. Pharmacol. 50 1998 955 964
19. A. Femenía-Font, C. Balaguer-Fernandez, V. Merino, V. Rodilla, and A. López-Castellano Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate Eur. J. Pharm. Biopharm. 61 2005 50 55
20. S.A. Ibrahim, and S.K. Li Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship Pharm. Res. 27 2010 115 125
21. A. Femenía-Font, C. Balaguer-Fernández, V. Merino, and A. López-Castellano Iontophoretic trandermal delivery of sumatriptan: effect of current density and ionic strength J. Pharm. Sci. 94 2005 2183 2186
22. J. Cazares-Delgadillo, A. Naik, A. Ganem-Rondero, D. Quintanar-Guerrero, and Y.N. Kalia Transdermal delivery of cytochrome C-A 12.4 kDa protein-across intact skin by constant-current iontophoresis Pharm. Res. 24 2007 1360 1368
23. S. del Rio-Sancho, C.E. Serna-Jiménez, A. Calatayud-Pascual, C. Balaguer-Fernández, A. Femenía-Font, V. Merino, A. López-Castellano, High-perfomance liquid chromatographic ultraviolet determination of memantine hydrochloride, (2012) Unpublished results.
24. R.J. Scheuplein Mechanism of percuaneous absorption II. Transient diffusion and the relative importance of various routes of skin penetration J. Invest. Dermatol. 48 1967 79 88
25. C. Balaguer-Fernández, A. Femenía-Font, S. del Rio-Sancho, V. Merino, and A. López- Castellano Sumatriptan succinate transdermal delivery systems for the treatment of migraine J. Pharm. Sci. 97 2008 2102 2109
26. D. Marro, R.H. Guy, and M.B. Delgado-Charro Characterization of the iontophoretic permselectivity properties of human and pig skin J. Control. Release 70 2001 213 217
27. B. Berner, G.C. Mazzenga, J.H. Otte, R.J. Steffens, R.H. Juang, and C.D. Ebert Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin J. Pharm. Sci. 78 1989 402 407
28. N.A. Megrab, A.C. Williams, and B.W. Barry Oesradiol permeation across human skin, silastic and snake membranes: the effects of ethanol/water co-solvent systems Int. J. Pharm. 116 1995 101 112
29. N.S. Thomas, and R. Panchagnula Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action Eur. J. Pharm. Sci. 18 2003 71 79
30. A. López, F. Llinares, C. Cortell, and M. Herráez Comparative enhancer effects of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities Int. J. Pharm. 202 2000 133 140
31. J. Borrás-Blasco, A. López, M.J. Morant, O. Díez Sales, and M. Herráez Dominguez Influence of sodium lauryl sulfate on the in vitro percutaneous absorption of compounds with different lipophilicity Eur. J. Pharm. Sci. 5 1997 15 22
32. J. Borras-Blasco, O. Diez-Sales, A. Lopez, and M. Herraez-Dominguez A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate Int. J. Pharm. 269 2004 121 129
33. R.R. Fitzgerald, and J.D. Walters Accumulation of topical naproxen by cultured oral epithelium J. Dent. Res. 86 2007 775 779
34. N. Kanikkannan, and M. Singh Skin permeation enhancement effect and skin irritation of saturated fatty alcohols Int. J. Pharm. 248 2002 219 228
35. H. Okabe, Y. Obata, K. Takayama, and T. Nagai Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes Drug Des. Deliv. 6 1990 229 238
36. J. Zhang, M. Liu, H. Jin, L. Deng, J. Xing, and A. Dong In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity AAPS PharmSci. Technol. 11 2010 894 903
37. A. López, M.A. Pellett, F. Llinares, O. Diez-Sales, M. Herraez, and J. Hadgraft The enhancer effect of several phenyl alcohols on percutaneous penetration of 5-fluorouracil Pharm. Res. 14 1997 681 685
38. E.W. Smith, and H.I. Maibach Percutaneous Penetration Enhancers 1995 CRC Press Boca Raton, FL 312
39. B.N. Singh, R.B. Singh, and J. Singh Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum Int. J. Pharm. 298 2005 98 107
40. M.A. Yamane, A.C. Williams, and B.W. Barry Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry Int. J. Pharm. 116 1995 237 251
41. J. Hirvonen, J.H. Rytting, P. Paronen, and A. Urtti Dodecyl N, N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin Pharm. Res. 8 1991 933 937
42. A.F. El-Kattan, C.S. Asbill, and B.B. Michniak The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems Int. J. Pharm. 198 2000 179 189
43. S.A. Ibrahim, and S.K. Li Effects of chemical enhancers on human epidermal membrane: structure-enhancement relationship based on maximum enhancement (E(max)) J. Pharm. Sci. 98 2009 926 944
44. L.C. Fuhrman Jr, B.B. Michniak, C.R. Behl, and A.W. Malick Effect of novel penetration enhancers on the transdermal delivery of hydrocortisone: an in vitro species comparison J. Control. Release 45 1997 199 206
45. A. Mittal, U.V. Sara, A. Ali, and M. Aqil The effect of penetration enhancers on permeation kinetics of nitrendipine in two different skin models Biol. Pharm. Bull. 31 2008 1766 1772
46. J.C. Smith, and W.J. Irwin Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin Int. J. Pharm. 210 2000 69 82
47. V. Merino, T. Mico-Albinana, A. Nacher, O. Diez-Sales, M. Herraez, and M. Merino-Sanjuan Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis J. Pharm. Pharmacol. 60 2008 415 420
48. B.J. Drakulic, I.O. Juranic, S. Eric, and M. Zloh Role of complexes formation between drugs and penetration enhancers in transdermal delivery Int. J. Pharm. 363 2008 40 49
49. L.B. Sheiner, and S.L. Beal Some suggestions for measuring predictive performance J. Pharmacokinet. Biopharm. 9 1981 503 512
50. A.C. Williams, and B.W. Barry Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement Pharm. Res. 8 1991 17 24
51. D. Lewis, and J. Hadgraft Mixed monolayers of dipalmitolphospatidyl- choline with Azone or oleic acid at the air-water interface Int. J. Pharm. Sci. 75 1990 176 181
52. K. Sugibayashi, S. Nakayama, T. Seki, K. Hosoya, and Y. Morimoto Mechanism of skin penetration-enhancing effect by laurocapram J. Pharm. Sci. 81 1992 58 64
53. O. Díez-Sales, A.C. Watkinson, M. Herráez-Domínguez, C. Javaloyes, and J. Hadgraft A mechanistic investigation of the in vitro human permeation enhancing effect of Azone® Int. J. Pharm. 129 1996 33 40
54. N. Dixit, V. Bali, S. Baboota, A. Ahuja, and J. Ali Iontophoresis - an approach for controlled drug delivery: a review Curr. Drug Deliv. 4 2007 1 10
55. D. Marro, Y.N. Kalia, M.B. Delgado-Charro, and R.H. Guy Contributions of electromigration and electroosmosis to iontophoretic drug delivery Pharm. Res. 18 2001 1701 1708
56. J. Hirvonen, and R.H. Guy Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances Pharm. Res. 14 1997 1258 1263
57. Y. Tashiro, M. Sami, S. Shichibe, Y. Kato, E. Hayakawa, and K. Itoh Effect of lipophilicity on in vivo iontophoretic delivery. II. Beta-blockers Biol. Pharm. Bull. 24 2001 671 677
58. Y. Tashiro, S. Shichibe, Y. Kato, E. Hayakawa, and K. Itoh Effect of lipophilicity on in vivo iontophoretic delivery. I. NSAIDs Biol. Pharm. Bull. 24 2001 278 283
59. B. Mudry, R.H. Guy, and M. Begona Delgado-Charro Prediction of iontophoretic transport across the skin J. Control. Release 111 2006 362 367
60. G.L. Wenk, G. Quack, H.J. Moebius, and W. Danysz No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use Life Sci. 66 2000 1079 1083